What is IQVIA's business focus and history?

IQVIA is a publicly traded company based in Durham, North Carolina, founded in 2016 by Dennis Gillings. It operates as a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA has raised $1.74 million in funding and reported a revenue of $15.4 billion in 2024. The company has 88,000 employees and its top competitors include Medidata, Verily, and TriNetX.

IQVIA Corporate Details & Core Services

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science to enable companies to develop new approaches to clinical development and commercialization, speed innovation, and accelerate improvements in healthcare outcomes.

IQVIA Contact Information & Official Links

Website https://www.iqvia.com
Social        
Email id Sandra.Woodlief@iqvia.com
Phone number 866.267.4479
Head office address Durham, North Carolina, United States
Tags Healthcare Clinical Research Data Analytics Technology Solutions

What are IQVIA's Key Business Metrics & Stats?

No of employees 88000
Founded year 2016
Type public
SAICS CODE 8731
NAICS Code 541715
Industry Healthcare
Location Durham, North Carolina, United States
Subsidiary Company linguamatics.com
Stock Name IQV (NYSE)
Pricing Strategy Custom Pricing
IQVIA IQV (NYSE) Firmographic Snapshot 2026 2016 Founded Year 88000 Global Employees United States Headquarters Healthcare Industry Public Type Verified by DexterAgent.ai

How much funding has IQVIA raised to date?

Name Description
Funding Amount USD 1.7 Million
Stage Multiple Rounds
Latest Valuation 15.4 Billion (USD)
Lead Investor TPG
Investors TPG, HHS, CPP Investments, European Union

What are IQVIA's Core Products?

Name Description
IQVIA CORE Combines big data, advanced technology, analytics, and extensive industry knowledge to drive healthcare forward.
IQVIA Connected Intelligence Delivers powerful insights by connecting data, technology, and analytics to accelerate clinical development and commercialization.

What are the latest developments at IQVIA?

Date Type Description
July, 2023 Partnership IQVIA announced a partnership with RED to support laboratory system strengthening.
January, 2019 Acquisition IQVIA acquired Linguamatics, a provider of text mining systems for pharmaceutical and healthcare applications.

What industry awards and recognitions has IQVIA received?

Date Type Description
February, 2026 Recognition IQVIA named to Fortune's World's Most Admired Companies list for the ninth consecutive year.

IQVIA VS Medidata Solutions VS Verily VS TriNetX VS Signant Health VS Western Institutional Review Board : 2026 Comparison

Feature IQVIA Medidata Solutions Verily TriNetX Signant Health Western Institutional Review Board
Core Strengths IQVIA CORE, IQVIA Connected Intelligence Medidata Rave, Medidata Patient Cloud, Medidata Acorn AI Verily Me, Lightpath, Viewpoint, Sightline TriNetX LIVE™, EVIDEX® eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies, Endpoint Quality IRB Review Services, IBC Services, Data Monitoring Services
Founded Year 2016 1999 2015 2013 2000 1968
Stock Name/Ticker IQV (NYSE)
Type public private private private private private
Global Employees 88000 2800 1259 272 2000 200
Revenue (Annual) $15.4 Billion(2024) $636 Million(2018) $559 Million(2022) $38.1 Million(2023)   $7.3 Million(2025)
Headquarters Durham, North Carolina, United States New York, New York, United States Dallas, Texas, United States Cambridge, Massachusetts, USA Blue Bell, Pennsylvania, United States Olympia, Washington, United States
Latest Valuation $15.4 Billion $5.8 Billion $0 $114.2 Million $0 $0
LATEST REVENUE (TRILLIONS USD) EMPLOYEE COUNT (THOUSANDS) INNOVATORS VISIONARIES DISRUPTORS GIANTS Medidata Solutions 636 | 2800 Verily 559 | 1259 TriNetX 38.1 | 272 Western Institutional Review Board 7.3 | 200 Competitive Landscape 2026 DexterAgent.ai
Name Description
Legal Name IQVIA Holdings Inc.
Cin number
GST number
Registration number US46266C1053

Who is in IQVIA's executive leadership team?

Name Designation
CEO Ari Bousbib
President EMEA Alistair Grenfell
Senior Vice President & General Manager, North Europe Tim Sheppard
Vice President & General Manager, France Frank Swaelens

Where are IQVIA's primary office locations?

City Country
Durham United States
Cambridge United Kingdom

What are the current business signals and market intelligence for IQVIA?

Spending next 3 months Technology Solutions, Clinical Research Services, Data Analytics
Pain points Data Integration, Regulatory Compliance, Clinical Trial Efficiency
Sales motion Direct Sales, Partnerships
Buyer Persona Chief Medical Officer, Head of Clinical Operations, Director of Data Analytics
Type of customer Pharmaceutical Companies, Biotech Firms, Healthcare Providers, Medical Device Manufacturers
Key customer domain pfizer.com, novartis.com, johnsonandjohnson.com
Annual ACV $500,000 - $1,000,000

What is IQVIA's annual revenue history?

Year Revenue (USD)
2024 15.4 Billion

What are IQVIA's risk management and compliance ratings?

GDPR RIsk Yes
Privacy Risk Yes
Company Ratings 4
Glassdoor Rating 3.8

What are IQVIA's business model and service classifications?

Saas Yes
Offline Stores No
Service Yes
Ecommerce No
Exporter Yes
Mobile App No
Retail No
B2B Yes
B2C No
Manufacturing No
Wholesale No
Importer No
Get Company Intelligence in API
(Price is 0.1 USD/Record - pay as you go)

 

Get Company Intelligence in API
(Price is 0.1 USD/Record - pay as you go)